Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$2.4bn reported value +29.0% vs Q1 2026
89positions
46.5%in top 10
29 new 23 added 20 reduced 26 sold out vs Q1 2026

Options: 2 call positions ($38.2m notional), 1 put positions ($56.2m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 1,500,000 $280.9m11.53% 11.53% UnchangedShares held: Q3 2025 400.0k, Q4 2025 1.2m, Q1 2026 1.5m, Q2 2026 1.5m
2 INSMED INC COM PAR $.01 INSM INSM 1,600,000 $170.6m7.00% 7.00% AddedShares held: Q3 2025 1.6m, Q4 2025 1.2m, Q1 2026 1.5m, Q2 2026 1.6m +100.0k +100,000 6.7%
3 CYTOKINETICS INC COM NEW CYTK CYTK 1,600,000 $136.3m5.59% 5.59% UnchangedShares held: Q3 2025 1.4m, Q4 2025 1.4m, Q1 2026 1.6m, Q2 2026 1.6m
4 CVS HEALTH CORP COM CVS CVS 1,100,000 $113.8m4.67% 4.67% AddedShares held: Q3 2025 200.0k, Q4 2025 500.0k, Q1 2026 150.0k, Q2 2026 1.1m +950.0k +950,000 633.3%
5 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,000,000 $81.3m3.33% 3.33% AddedShares held: Q3 2025 1.5m, Q4 2025 1.5m, Q1 2026 1.6m, Q2 2026 2.0m +400.0k +400,000 25.0%
6 VERA THERAPEUTICS INC CL A VERA VERA 1,750,000 $75.1m3.08% 3.08% AddedShares held: Q3 2025 1.7m, Q4 2025 1.8m, Q1 2026 1.6m, Q2 2026 1.8m +150.0k +150,000 9.4%
7 AXSOME THERAPEUTICS INC COM AXSM AXSM 300,000 $73.4m3.01% 3.01% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 35.0k, Q2 2026 300.0k +265.0k +265,000 757.1%
8 CARDINAL HEALTH INC COM CAH CAH 300,000 $71.3m2.92% 2.92% AddedShares held: Q3 2025 130.0k, Q4 2025 200.0k, Q1 2026 270.0k, Q2 2026 300.0k +30.0k +30,000 11.1%
9 ROIVANT SCIENCES LTD SHS ROIV ROIV 2,000,000 $70.8m2.90% 2.90% UnchangedShares held: Q3 2025 750.0k, Q4 2025 850.0k, Q1 2026 2.0m, Q2 2026 2.0m
10 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 550,000 $61.1m2.51% 2.51% ReducedShares held: Q3 2025 220.0k, Q4 2025 475.0k, Q1 2026 600.0k, Q2 2026 550.0k -50.0k -50,000 -8.3%
11 EDWARDS LIFESCIENCES CORP COM EW EW 625,000 $56.5m2.32% 2.32% AddedShares held: Q3 2025 200.0k, Q4 2025 325.0k, Q1 2026 170.0k, Q2 2026 625.0k +455.0k +455,000 267.6%
12 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 2,000,000 $47.6m1.95% 1.95% ReducedShares held: Q3 2025 1.6m, Q4 2025 2.2m, Q1 2026 2.6m, Q2 2026 2.0m -575.0k -575,000 -22.3%
13 MERCK & CO INC COM MRK MRK 350,000 $45.0m1.85% 1.85% ReducedShares held: Q3 2025 0, Q4 2025 250.0k, Q1 2026 425.0k, Q2 2026 350.0k -75.0k -75,000 -17.6%
14 QUEST DIAGNOSTICS INC COM DGX DGX 200,000 $42.4m1.74% 1.74% AddedShares held: Q3 2025 85.0k, Q4 2025 75.0k, Q1 2026 60.0k, Q2 2026 200.0k +140.0k +140,000 233.3%
15 UNIQURE NV SHS QURE QURE 900,000 $41.5m1.70% 1.70% UnchangedShares held: Q3 2025 600.0k, Q4 2025 900.0k, Q1 2026 900.0k, Q2 2026 900.0k
16 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 750,000 $41.2m1.69% 1.69% AddedShares held: Q3 2025 100.0k, Q4 2025 300.0k, Q1 2026 500.0k, Q2 2026 750.0k +250.0k +250,000 50.0%
17 BOSTON SCIENTIFIC CORP COM BSX BSX 900,000 $38.4m1.58% 1.58% AddedShares held: Q3 2025 300.0k, Q4 2025 225.0k, Q1 2026 550.0k, Q2 2026 900.0k +350.0k +350,000 63.6%
18 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 550,000 $38.4m1.57% 1.57% ReducedShares held: Q3 2025 1.1m, Q4 2025 750.0k, Q1 2026 1.2m, Q2 2026 550.0k -700.0k -700,000 -56.0%
19 ABBOTT LABS COM ABT ABT 400,000 $36.3m1.49% 1.49% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
20 UNITEDHEALTH GROUP INC COM UNH UNH 85,000 $35.3m1.45% 1.45% NewShares held: Q3 2025 0, Q4 2025 50.0k, Q1 2026 0, Q2 2026 85.0k
21 LIFESTANCE HEALTH GROUP INC COM LFST LFST 3,000,000 $32.1m1.32% 1.32% ReducedShares held: Q3 2025 1.5m, Q4 2025 3.0m, Q1 2026 4.3m, Q2 2026 3.0m -1.3m -1,300,000 -30.2%
22 NOVARTIS AG SPONSORED ADR NVS NVS 200,000 $31.3m1.29% 1.29% ReducedShares held: Q3 2025 200.0k, Q4 2025 250.0k, Q1 2026 250.0k, Q2 2026 200.0k -50.0k -50,000 -20.0%
23 TANGO THERAPEUTICS INC COM TNGX TNGX 1,000,000 $31.3m1.28% 1.28% AddedShares held: Q3 2025 0, Q4 2025 200.0k, Q1 2026 450.0k, Q2 2026 1.0m +550.0k +550,000 122.2%
24 TENET HEALTHCARE CORP COM NEW THC THC 165,000 $30.9m1.27% 1.27% NewShares held: Q3 2025 300.0k, Q4 2025 100.0k, Q1 2026 0, Q2 2026 165.0k
25 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 325,000 $28.9m1.18% 1.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 325.0k
26 NOVO-NORDISK A S ADR NVO NVO 600,000 $28.8m1.18% 1.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 600.0k
27 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 550,000 $25.9m1.06% 1.06% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 400.0k, Q2 2026 550.0k +150.0k +150,000 37.5%
28 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 150,000 $25.3m1.04% 1.04% UnchangedShares held: Q3 2025 150.0k, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
29 REGENERON PHARMACEUTICALS COM REGN REGN 40,000 $24.9m1.02% 1.02% ReducedShares held: Q3 2025 50.0k, Q4 2025 105.0k, Q1 2026 85.0k, Q2 2026 40.0k -45.0k -45,000 -52.9%
30 BIOGEN INC COM BIIB BIIB 100,000 $21.6m0.89% 0.89% AddedShares held: Q3 2025 0, Q4 2025 100.0k, Q1 2026 60.0k, Q2 2026 100.0k +40.0k +40,000 66.7%
31 TRAVERE THERAPEUTICS INC COM TVTX TVTX 375,000 $21.3m0.87% 0.87% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 375.0k
32 LANTHEUS HLDGS INC COM LNTH LNTH 190,000 $21.1m0.86% 0.86% AddedShares held: Q3 2025 0, Q4 2025 100.0k, Q1 2026 125.0k, Q2 2026 190.0k +65.0k +65,000 52.0%
33 GLAUKOS CORP COM GKOS GKOS 150,000 $21.0m0.86% 0.86% ReducedShares held: Q3 2025 100.0k, Q4 2025 325.0k, Q1 2026 175.0k, Q2 2026 150.0k -25.0k -25,000 -14.3%
34 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,900,000 $20.6m0.84% 0.84% AddedShares held: Q3 2025 900.0k, Q4 2025 1.2m, Q1 2026 1.4m, Q2 2026 1.9m +500.0k +500,000 35.7%
35 BRIDGEBIO PHARMA INC COM BBIO BBIO 275,000 $20.5m0.84% 0.84% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 275.0k, Q2 2026 275.0k
36 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 40,000 $19.9m0.82% 0.82% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 40.0k, Q2 2026 40.0k
37 ALUMIS INC COM ALMS ALMS 700,000 $19.7m0.81% 0.81% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 800.0k, Q2 2026 700.0k -100.0k -100,000 -12.5%
38 ELEVANCE HEALTH INC COM ELV ELV 50,000 $19.3m0.79% 0.79% ReducedShares held: Q3 2025 50.0k, Q4 2025 60.0k, Q1 2026 75.0k, Q2 2026 50.0k -25.0k -25,000 -33.3%
39 CENTENE CORP DEL COM CNC CNC 300,000 $19.3m0.79% 0.79% ReducedShares held: Q3 2025 400.0k, Q4 2025 650.0k, Q1 2026 650.0k, Q2 2026 300.0k -350.0k -350,000 -53.9%
40 ERASCA INC COM ERAS ERAS 1,000,000 $18.3m0.75% 0.75% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 700.0k, Q2 2026 1.0m +300.0k +300,000 42.9%
41 ELI LILLY & CO COM LLY LLY 15,000 $18.0m0.74% 0.74% UnchangedShares held: Q3 2025 20.0k, Q4 2025 20.0k, Q1 2026 15.0k, Q2 2026 15.0k
42 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 200,000 $16.3m0.67% 0.67% ReducedShares held: Q3 2025 225.0k, Q4 2025 100.0k, Q1 2026 300.0k, Q2 2026 200.0k -100.0k -100,000 -33.3%
43 ENVISTA HOLDINGS CORPORATION COM NVST NVST 600,000 $15.8m0.65% 0.65% AddedShares held: Q3 2025 550.0k, Q4 2025 500.0k, Q1 2026 350.0k, Q2 2026 600.0k +250.0k +250,000 71.4%
44 MEDTRONIC PLC SHS MDT MDT 200,000 $15.6m0.64% 0.64% NewShares held: Q3 2025 150.0k, Q4 2025 675.0k, Q1 2026 0, Q2 2026 200.0k
45 WATERS CORP COM WAT WAT 40,000 $15.0m0.62% 0.62% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 40.0k
46 LIVANOVA PLC SHS LIVN LIVN 180,000 $14.8m0.61% 0.61% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 180.0k +30.0k +30,000 20.0%
47 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 675,000 $14.3m0.59% 0.59% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 675.0k +525.0k +525,000 350.0%
48 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 25,000 $13.4m0.55% 0.55% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 25.0k, Q2 2026 25.0k
49 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 40,000 $13.4m0.55% 0.55% UnchangedShares held: Q3 2025 0, Q4 2025 40.0k, Q1 2026 40.0k, Q2 2026 40.0k
50 ALTO NEUROSCIENCE INC COM SHS ANRO ANRO 500,000 $13.2m0.54% 0.54% UnchangedShares held: Q3 2025 400.0k, Q4 2025 375.0k, Q1 2026 500.0k, Q2 2026 500.0k
51 MINERALYS THERAPEUTICS INC COM MLYS MLYS 450,000 $12.1m0.50% 0.50% ReducedShares held: Q3 2025 1.5m, Q4 2025 750.0k, Q1 2026 750.0k, Q2 2026 450.0k -300.0k -300,000 -40.0%
52 XENON PHARMACEUTICALS INC COM XENE XENE 200,000 $12.1m0.50% 0.50% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 200.0k
53 ASCENDIS PHARMA A/S ORD SHS ASND ASND 45,000 $12.0m0.49% 0.49% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 45.0k
54 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 400,000 $11.8m0.48% 0.48% AddedShares held: Q3 2025 300.0k, Q4 2025 0, Q1 2026 200.0k, Q2 2026 400.0k +200.0k +200,000 100.0%
55 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 90,000 $10.7m0.44% 0.44% NewShares held: Q3 2025 65.0k, Q4 2025 130.0k, Q1 2026 0, Q2 2026 90.0k
56 BIOHAVEN LTD COM BHVN BHVN 700,000 $10.4m0.43% 0.43% ReducedShares held: Q3 2025 650.0k, Q4 2025 1.5m, Q1 2026 1.0m, Q2 2026 700.0k -300.0k -300,000 -30.0%
57 BEAM THERAPEUTICS INC COM BEAM BEAM 300,000 $10.3m0.42% 0.42% UnchangedShares held: Q3 2025 400.0k, Q4 2025 550.0k, Q1 2026 300.0k, Q2 2026 300.0k
58 INTEGRA LIFESCIENCES HLDGS C COM NEW IART IART 550,000 $9.9m0.41% 0.41% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 550.0k
59 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 150,000 $9.6m0.39% 0.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
60 REGENXBIO INC COM RGNX RGNX 800,000 $9.6m0.39% 0.39% ReducedShares held: Q3 2025 1.1m, Q4 2025 1.2m, Q1 2026 1.5m, Q2 2026 800.0k -700.0k -700,000 -46.7%
61 ABSCI CORPORATION COM ABSI ABSI 800,000 $9.3m0.38% 0.38% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 800.0k
62 BRUKER CORP COM BRKR BRKR 150,000 $9.0m0.37% 0.37% NewShares held: Q3 2025 0, Q4 2025 125.0k, Q1 2026 0, Q2 2026 150.0k
63 CENCORA INC COM COR COR 30,000 $8.5m0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.0k
64 COGENT BIOSCIENCES INC COM COGT COGT 200,000 $7.7m0.32% 0.32% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 350.0k, Q2 2026 200.0k -150.0k -150,000 -42.9%
65 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 150,000 $7.6m0.31% 0.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
66 BIOAGE LABS INC COM BIOA BIOA 300,000 $7.4m0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 300.0k
67 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 30,000 $7.2m0.30% 0.30% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 30.0k
68 SANA BIOTECHNOLOGY INC COM SANA SANA 2,000,000 $7.0m0.29% 0.29% ReducedShares held: Q3 2025 2.0m, Q4 2025 3.0m, Q1 2026 3.2m, Q2 2026 2.0m -1.2m -1,200,000 -37.5%
69 INVENTIVA SA ADS IVA IVA 1,520,000 $5.7m0.24% 0.24% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 400.0k, Q2 2026 1.5m +1.1m +1,120,000 280.0%
70 PROTARA THERAPEUTICS INC COM STK TARA TARA 1,500,000 $5.7m0.24% 0.24% ReducedShares held: Q3 2025 1.4m, Q4 2025 2.2m, Q1 2026 1.8m, Q2 2026 1.5m -250.0k -250,000 -14.3%
71 ALKERMES PLC SHS ALKS ALKS 100,000 $5.2m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
72 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 150,000 $4.9m0.20% 0.20% UnchangedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 150.0k, Q2 2026 150.0k
73 KARDIGAN INC COM KARD KARD 200,000 $4.8m0.20% 0.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
74 BIONTECH SE SPONSORED ADS BNTX BNTX 50,000 $4.7m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
75 INSPIRE MED SYS INC COM INSP INSP 100,000 $4.5m0.18% 0.18% NewShares held: Q3 2025 120.0k, Q4 2025 75.0k, Q1 2026 0, Q2 2026 100.0k
76 TREVI THERAPEUTICS INC COM TRVI TRVI 200,000 $3.7m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
77 IDEAYA BIOSCIENCES INC COM IDYA IDYA 100,000 $3.7m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
78 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 100,000 $3.7m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
79 SAVARA INC COM SVRA SVRA 600,000 $3.7m0.15% 0.15% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 600.0k, Q2 2026 600.0k
80 RELMADA THERAPEUTICS INC COM RLMD RLMD 500,000 $3.5m0.14% 0.14% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 450.0k, Q2 2026 500.0k +50.0k +50,000 11.1%
81 MOBIA MED INC COMMON STOCK MOBI MOBI 250,000 $3.4m0.14% 0.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
82 SIONNA THERAPEUTICS INC COM SION SION 75,000 $3.3m0.14% 0.14% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 50.0k, Q2 2026 75.0k +25.0k +25,000 50.0%
83 VERADERMICS INC COMMON STOCK MANE MANE 25,000 $3.1m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 25.0k
84 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 1,350,000 $2.7m0.11% 0.11% UnchangedShares held: Q3 2025 0, Q4 2025 1.8m, Q1 2026 1.4m, Q2 2026 1.4m
85 REZOLUTE INC COM NEW RZLT RZLT 500,000 $2.6m0.11% 0.11% ReducedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 500.0k -1.5m -1,500,000 -75.0%
86 DENALI THERAPEUTICS INC COM DNLI DNLI 100,000 $2.6m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
87 TENAX THERAPEUTICS INC COM NEW TENX TENX 167,000 $2.4m0.10% 0.10% UnchangedShares held: Q3 2025 167.0k, Q4 2025 167.0k, Q1 2026 167.0k, Q2 2026 167.0k
88 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 100,000 $1.3m0.05% 0.05% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 100.0k -50.0k -50,000 -33.3%
89 AURA BIOSCIENCES INC COM AURA AURA 170,000 $1.2m0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 170.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASTRAZENECA PLC AZN AZN 250,000 $49.3m250.0k shares
ASCENDIS PHARMA A/S 115,000 $26.3m115.0k shares
FRESENIUS MEDICAL CARE AG FMS FMS 775,000 $17.5m775.0k shares
INTUITIVE SURGICAL INC ISRG ISRG 35,000 $16.1m35.0k shares
TARSUS PHARMACEUTICALS INC TARS TARS 200,000 $14.0m200.0k shares
GILEAD SCIENCES INC GILD GILD 100,000 $13.9m100.0k shares
ELANCO ANIMAL HEALTH INC ELAN ELAN 550,000 $13.2m550.0k shares
DIANTHUS THERAPEUTICS INC DNTH DNTH 150,000 $12.6m150.0k shares
DEXCOM INC DXCM DXCM 175,000 $11.0m175.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 325,000 $10.9m325.0k shares
DISC MEDICINE INC IRON IRON 170,000 $10.9m170.0k shares
NURIX THERAPEUTICS INC NRIX NRIX 700,000 $10.8m700.0k shares
COOPER COS INC COO COO 150,000 $10.7m150.0k shares
THERMO FISHER SCIENTIFIC INC TMO TMO 20,000 $9.8m20.0k shares
IONIS PHARMACEUTICALS INC IONS IONS 125,000 $9.4m125.0k shares
CELCUITY INC CELC CELC 80,000 $9.1m80.0k shares
SYNDAX PHARMACEUTICALS INC SNDX SNDX 350,000 $8.2m350.0k shares
VIKING THERAPEUTICS INC VKTX VKTX 250,000 $8.1m250.0k shares
CAPRICOR THERAPEUTICS INC CAPR CAPR 200,000 $6.1m200.0k shares
IQVIA HLDGS INC IQV IQV 35,000 $6.0m35.0k shares
PROTAGONIST THERAPEUTICS INC PTGX PTGX 50,000 $5.3m50.0k shares
EVOMMUNE INC EVMN EVMN 225,000 $5.2m225.0k shares
ZIMMER BIOMET HOLDINGS INC ZBH ZBH 50,000 $4.5m50.0k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 100,000 $3.0m100.0k shares
MAZE THERAPEUTICS INC MAZE MAZE 100,000 $3.0m100.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
REVOLUTION MEDICINES INC RVMD · Put RVMDPut 300,000 $56.2m300.0k shares Reduced
IONIS PHARMACEUTICALS INC IONS · Call IONSCall 300,000 $23.8m300.0k shares New
NOVO-NORDISK A S NVO · Call NVOCall 300,000 $14.4m300.0k shares New